Prognostic Significance of Subtype Classification for Short- and Long-Term Survival in Breast Cancer Survival Time Holds the Key 英文参考文献.docVIP

Prognostic Significance of Subtype Classification for Short- and Long-Term Survival in Breast Cancer Survival Time Holds the Key 英文参考文献.doc

  1. 1、本文档共3页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  5. 5、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  6. 6、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  7. 7、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  8. 8、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
Prognostic Significance of Subtype Classification for Short- and Long-Term Survival in Breast Cancer Survival Time Holds the Key 英文参考文献

Perspective PrognosticSignificanceofSubtypeClassificationfor Short-andLong-TermSurvivalinBreastCancer:Survival TimeHoldstheKey StefanAmbs* LaboratoryofHumanCarcinogenesis(LHC),CenterforCancerResearch(CCR),NationalCancerInstitute(NCI),Bethesda,Maryland,UnitedStatesofAmerica ‘‘Westilllacktheabilityto accuratelypredictsurvival amongbreastcancerpatients withearly-stagedisease’’ teristics [7,8]. They include two estrogen receptor (ER)-positive subtypes, termed luminal A and B, and three ER-negative subtypes, termed basal-like, HER2-posi- tive, and normal breast-like tumors. Lu- minal tumors develop more frequently than the other subtypes and share many featureswithluminalepithelialcellslining the mammary ducts, but tumors in the luminal B subgroup also aberrantly over- express the HER2 receptor or prolifera- tion marker genes that distinguish them from the HER2-negative luminal A tu- mors.Basal-likebreastcancerhassimilar- ities with normal breast basal epithelial cellsandiscommonlyidentifiedbyalack ofERandHER2receptorexpressionand bytheexpressionofeithercytokeratin5/6 LinkedResearchArticle This Perspective discusses the fol- lowingnewstudypublishedinPLoS Medicine: Advancesinhormonetherapyandcom- bination chemotherapy have led to signifi- cant declines in disease recurrence and mortalityduetobreastcancer[1,2].How- ever, the burden of developing a deadly diseaseremainsunequal.Adiseasediagnosis at age 50 or younger is still more likely to have a fatal outcome than the same diagnosis at an older age. Moreover, African-American women and women di- agnosed with estrogen, progesterone, and HER2 receptor–negative disease (termed triple-negative breast cancer) continue to experienceanexcessivemortalityandhave not benefited from the advances in breast cancer therapy as much as other patient groups[3,4].Currently,about10%ofbreast cancerpatientswillsuccumbtothedisease withinthefirst5yearsfollowingtheinitial diagnosis[5],despitemanybeingdiagnosed withanearly-stagedisease.Therel

您可能关注的文档

文档评论(0)

sheppha + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

版权声明书
用户编号:5134022301000003

1亿VIP精品文档

相关文档